Cargando…

Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression

Major depressive disorder (MDD) is a major cause of disability in adults. MDD is both a comorbidity and a risk factor for Alzheimer’s disease (AD), and regular physical exercise has been associated with reduced incidence and severity of MDD and AD. Irisin is an exercise-induced myokine derived from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima-Filho, Ricardo, Fortuna, Juliana S., Cozachenco, Danielle, Isaac, Alinny R., Lyra e Silva, Natalia, Saldanha, Alice, Santos, Luis E., Ferreira, Sergio T., Lourenco, Mychael V., De Felice, Fernanda G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2023
Materias:	Research Article: New Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927507/ https://www.ncbi.nlm.nih.gov/pubmed/36697257 http://dx.doi.org/10.1523/ENEURO.0256-22.2023

Ejemplares similares

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
por: Lourenco, Mychael V., et al.
Publicado: (2019)

FNDC5/Irisin: Physiology and Pathophysiology
por: Waseem, Rashid, et al.
Publicado: (2022)

Irisin stimulates protective signaling pathways in rat hippocampal neurons
por: Lourenco, Mychael V., et al.
Publicado: (2022)

Expression of Irisin/FNDC5 in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2022)

Progress and Challenges in the Biology of FNDC5 and Irisin
por: Maak, Steffen, et al.
Publicado: (2021)

Irisin/FNDC5: A participant in camel metabolism
por: Kirat, Doaa, et al.
Publicado: (2021)

Irisin Precursor FNDC5 and Glycemic Control in Patients With Type 2 Diabetes
por: Lima Mágero, Felipe Rodrigues, et al.
Publicado: (2021)

FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine
por: Roca-Rivada, Arturo, et al.
Publicado: (2013)

The diagnostic value of FNDC5/Irisin in renal Cell Cancer
por: Altay, Diler Us, et al.
Publicado: (2018)

Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment
por: Peng, Jin, et al.
Publicado: (2022)

Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
por: Lourenco, Mychael V., et al.
Publicado: (2020)

Association of the fibronectin type III domain–containing protein 5 rs1746661 single nucleotide polymorphism with reduced brain glucose metabolism in elderly humans
por: Lima-Filho, Ricardo A S, et al.
Publicado: (2023)

Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor?
por: Erickson, Harold P
Publicado: (2013)

Microarray expression profiling of fndc3a zebrafish mutants
por: Liedtke, Daniel, et al.
Publicado: (2022)

New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
por: Rabiee, Farzaneh, et al.
Publicado: (2020)

FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
por: Pignataro, Patrizia, et al.
Publicado: (2021)

Evaluation of Serum Concentration of the Myokine Irisin (FNDC5) in Patients with Age-Related
por: Turgut, Burak, et al.
Publicado: (2021)

Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer
por: Xu, Luyun, et al.
Publicado: (2022)

The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer
por: Cebulski, Kamil, et al.
Publicado: (2023)

Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis
por: Pérez-Sotelo, D., et al.
Publicado: (2017)

Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
por: Ribeiro, Felipe C., et al.
Publicado: (2023)

SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Locus Characterization and Gene Expression of Bovine FNDC5: Is the Myokine Irisin Relevant in Cattle?
por: Komolka, Katrin, et al.
Publicado: (2014)

Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC
por: Nowińska, Katarzyna, et al.
Publicado: (2022)

Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis
por: Sanesi, Lorenzo, et al.
Publicado: (2023)

Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-Small Cell Lung Cancer
por: Nowinska, Katarzyna, et al.
Publicado: (2019)

FNDC5/Irisin – Their Role in the Nervous System and as a Mediator for Beneficial Effects of Exercise on the Brain
por: Wrann, Christiane D.
Publicado: (2015)

Can Resistance Exercise Alter Irisin Levels and Expression Profiles of FNDC5 and UCP1 in Rats?
por: Reisi, Jalil, et al.
Publicado: (2016)

Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity
por: Zhou, Xin, et al.
Publicado: (2019)

Iditarod, a Drosophila homolog of the Irisin precursor FNDC5, is critical for exercise performance and cardiac autophagy
por: Cobb, Tyler, et al.
Publicado: (2023)

FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle
por: Varela-Rodríguez, B. M., et al.
Publicado: (2016)

FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020)

Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice
por: Jiang, Songling, et al.
Publicado: (2021)

Exercise-induced FNDC5/irisin protects nucleus pulposus cells against senescence and apoptosis by activating autophagy
por: Zhou, Wenxian, et al.
Publicado: (2022)

Dietary Intervention, When Not Associated With Exercise, Upregulates Irisin/FNDC5 While Reducing Visceral Adiposity Markers in Obese Rats
por: Furino, Vanessa de Oliveira, et al.
Publicado: (2021)

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
por: De Felice, Fernanda G., et al.
Publicado: (2015)

Serum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity
por: Zhu, Huijuan, et al.
Publicado: (2018)

NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin
por: Li, Dong-Jie, et al.
Publicado: (2021)

CircRNA AFF4 induced by KDM1A promotes osteogenic differentiation through FNDC5/Irisin pathway
por: Liu, Ansong, et al.
Publicado: (2022)

FNDC5/Irisin Inhibits the Inflammatory Response and Mediates the Aerobic Exercise-Induced Improvement of Liver Injury after Myocardial Infarction
por: Wang, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_udar7uhge6sps3phh1s9clacg5